GEVO
Gevo, Inc.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$1.21
−0.82%Year over year
Reported trailing growth
- Revenue
- +121.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +38.5%
- Operating cash flow
- +71.2%
Forward estimates
Based on analyst estimates
- Revenue
- +14.4%
- EBITDA
- +147.1%
- EPS
- +102.1%
Three-year CAGR
- Revenue
- +415.1%
- EBITDA
- +118.2%
- EBIT
- +79.2%
- Net income
- +57.0%
- EPS
- +58.8%
- Free cash flow
- +59.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026